4D Molecular Therapeutics, Inc.
NASDAQ:FDMT
3.24 (USD) • At close May 8, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||
| Net Income
| -160.868 | -100.837 | -107.494 | -71.317 | -56.693 | -49.306 | -9.551 | -11.223 |
| Depreciation & Amortization
| 6.705 | 5.749 | 3.88 | 3.02 | 1.443 | 1.004 | 0.697 | 0.626 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | 0.02 | 2.654 | 0 | 0 |
| Stock Based Compensation
| 26.116 | 19.665 | 17.121 | 13.799 | 4.984 | 3.541 | 1.377 | 0.256 |
| Change In Working Capital
| 0.537 | 0.63 | -1.336 | -15.534 | -0.711 | 0.259 | -8.777 | 18.539 |
| Accounts Receivables
| 0 | 0 | 0.047 | 1.439 | -0.508 | 0.146 | -0.803 | -0.32 |
| Inventory
| 0 | 0 | 0 | -4.536 | -0.591 | 2.926 | 0.175 | -0.053 |
| Accounts Payables
| 0.871 | 0.896 | -1.638 | 2.285 | 0.043 | 0.533 | 0.438 | -0.114 |
| Other Working Capital
| -0.334 | -0.266 | 0.255 | -14.722 | 0.345 | -3.346 | -8.587 | 19.026 |
| Other Non Cash Items
| -7.075 | -0.999 | 1.144 | 0.898 | 0.048 | 5.137 | 0.002 | 0.039 |
| Operating Cash Flow
| -134.585 | -75.792 | -86.685 | -69.134 | -50.909 | -36.711 | -16.252 | 8.237 |
| Investing Activities: | ||||||||
| Investments In Property Plant And Equipment
| 0 | -2.771 | -11.536 | -9.11 | -1 | -3.203 | -0.414 | -0.573 |
| Acquisitions Net
| 0 | 0 | 11.536 | 9.11 | 0 | 0 | 0 | 0.024 |
| Purchases Of Investments
| -467.652 | -54.802 | -153.313 | -168.57 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 169.001 | 0 | 147.799 | 5 | 0 | 0 | 0 | 8.224 |
| Other Investing Activites
| -3.786 | 173.29 | -11.536 | -9.11 | -1 | 0 | 0 | 0.024 |
| Investing Cash Flow
| -302.437 | 115.717 | -17.05 | -172.68 | -1 | -3.203 | -0.414 | 7.675 |
| Financing Activities: | ||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 331.412 | 148.344 | 2.73 | 114.296 | 205.658 | 0 | 0.105 | 0.016 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | -2.27 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 5.838 | 8.488 | 3.085 | 3.793 | 73.325 | -0.01 | 169.049 | 0 |
| Financing Cash Flow
| 337.25 | 156.832 | 3.085 | 118.089 | 278.983 | -2.195 | 84.577 | 0.016 |
| Other Information: | ||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -99.772 | 196.757 | -100.65 | -123.725 | 227.074 | -42.109 | 67.911 | 15.928 |
| Cash At End Of Period
| 149.336 | 249.108 | 52.351 | 153.001 | 276.726 | 49.652 | 91.761 | 23.85 |